戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 domain Abs have reinvigorated the concept of passive immunization.
2 to a more potent reagent for gene therapy or passive immunization.
3 protected mice from a lethal VV challenge by passive immunization.
4 ization, HSV-1 shedding, and latency through passive immunization.
5  T-helper cell subset 1 response and enables passive immunization.
6 mmunomodulatory effects as well as providing passive immunization.
7 antibodies for virus following active versus passive immunization.
8 transplantation can be reduced by aggressive passive immunization.
9 cued spatial reference memory deficits after passive immunization.
10  IgG-FcgammaR interactions during active and passive immunization.
11 otected against systemic GAS challenge after passive immunization.
12 apsule is a potential therapeutic target via passive immunization.
13 prevention of viral acquisition by active or passive immunization.
14 uction before initiating a 12 week course of passive immunization.
15  human immunodeficiency virus (HIV) has made passive immunization a potential strategy for the preven
16                                       Unlike passive immunization, active immunization, which is the
17        Our data support a mechanism by which passive immunization acts centrally to stimulate microgl
18                                              Passive immunization against beta-amyloid (Abeta) has be
19 rides, an iron scavenging protein, isdB, and passive immunization against clumping factor A and lipot
20                         We hypothesized that passive immunization against cryptosporidiosis could be
21 opes on defined antigens may provide optimal passive immunization against cryptosporidiosis.
22                                              Passive immunization against GPI reduced the number of i
23 utralizing antibodies that could be used for passive immunization against H5N1 virus or as guides for
24           sCD4-17b has potential utility for passive immunization against HIV-1 in several contexts,
25 n-sensitive P23 epitopes may have utility in passive immunization against murine C. parvum infection.
26         Therefore, we explored the effect of passive immunization against the CT of alpha-syn in the
27                  Herein, we demonstrate that passive immunization against the Vbeta8-targeting SAg st
28                                              Passive immunization altered the growth and vascularizat
29 Ab has an important potential in therapeutic passive immunization and could help HIV-1 infected patie
30 he importance of the antibody format in oral passive immunization and encourage future expression of
31 such infection that may be prevented by oral passive immunization and might avert recurrent economic
32 app = 200 nM) was tested in a mouse model of passive immunization and subsequent mole-equivalent chal
33 uorescence assays, growth inhibition assays, passive immunizations, and active immunizations indicate
34                         However, traditional passive immunization approaches carry the risk of Fcgamm
35 fic antibodies, acquired by either active or passive immunization, are sufficient to protect against
36    We demonstrate that HCV can be blocked by passive immunization, as well as showing that a recombin
37 noculation all showed protective activity in passive immunization assays.
38 thermore, when MIP-2 was depleted in vivo by passive immunization, bleomycin-induced pulmonary fibros
39                              Oral feed-based passive immunization can be a promising strategy to prol
40     Here we show that elements of active and passive immunization can be combined to create an effect
41 -CelTOS responses elicited by vaccination or passive immunization can inhibit sporozoite and ookinete
42                     Our results suggest that passive immunization can reduce VAbeta levels, and modul
43 ed by active immunization or administered by passive immunization confer protection against S. aureus
44 us and vaccine-heterologous strains, whereas passive immunization confers only vaccine-homologous pro
45                              To determine if passive immunization could decrease the incidence or sev
46                                Thus, anti-gB passive immunization decreased fetal infection and intra
47                                     However, passive immunization did prevent mortality from pneumoni
48 mited the study's ability to address whether passive immunization diminishes perinatal transmission.
49 n, highlighting their utility for evaluating passive immunization efficacy.
50  serum is sufficient to confer protection, a passive immunization experiment using pooled nHgbA antis
51                                 In addition, passive immunization experiments demonstrated that antib
52 virus (ZEBOV) have been successfully used in passive immunization experiments in rodent models, but h
53                        This was confirmed by passive immunization experiments in which the protective
54 al passive immunity in fish and fish-to-fish passive immunization experiments supports the concept of
55                                           In passive immunization experiments using challenge with wi
56 isms underlying host resistance, a series of passive immunization experiments were carried out using
57                     To test this hypothesis, passive immunization experiments were carried out with n
58 om a lethal intranasal challenge with WU2 in passive-immunization experiments in which 10 mug of the
59 only a subset of G(C) MAbs protected mice in passive-immunization experiments, while some nonneutrali
60 ntibodies (mAbs) has re-ignited the field of passive immunization for HIV-1 prevention.
61                            During studies of passive immunization for treatment of murine cryptococco
62                                              Passive immunization has been successfully employed for
63 soluble Abeta and tau levels after active or passive immunization in advanced aged 3xTg-AD mice that
64 omer-specific monoclonal antibody (TOMA) for passive immunization in mice expressing mutant human tau
65                                        Using passive immunization in mice, the O:4-specific antibodie
66                    Recommendations for using passive immunization in the general population or for th
67 l likely shape efforts to develop active and passive immunization interventions in response to the re
68              But most current strategies for passive immunization involve injection of antibodies for
69                                 As a result, passive immunization is an appropriate therapeutic optio
70                                Consequently, passive immunization is being considered for treating Al
71 ocked TIGR4 adhesion in vitro and, following passive immunization, it protected mice against challeng
72 c antibodies in both the sera and lungs, and passive immunization led to the reduction of B. bronchis
73  a longer period of active immunotherapy, or passive immunization, may be required to provide suffici
74 enal disease is prevented in both active and passive immunization models by antigen-specific IgG1; ot
75                   We have studied active and passive immunization models in mice to approach these is
76  and Thioflavin-S positive plaque load after passive immunization of 5XFAD mice.
77                                              Passive immunization of animals with a soluble TNF recep
78                                              Passive immunization of animals with anti-IL-12 serum i.
79                                              Passive immunization of B. burgdorferi-infected SCID mic
80 o the control normal mouse immunoglobulin G, passive immunization of BALB/c mice with MAb MoPn-23 res
81                                              Passive immunization of DENV-infected mice with polyclon
82                                              Passive immunization of hamsters with a mixture of toxin
83                                 In addition, passive immunization of mice demonstrated that antibody
84 n of rheumatoid arthritis (RA) by active and passive immunization of mice results in the development
85                                              Passive immunization of mice with a goat antiserum raise
86                                              Passive immunization of mice with anti-dPNAG-DT rabbit s
87 t, when performed during progression of HUS, passive immunization of mice with anti-Stx2 antibody pre
88                                          The passive immunization of mice with rabbit antimurine MCP-
89                                              Passive immunization of mice with rabbit antiserum confe
90                                   Active and passive immunization of mice with recombinant Arp or Arp
91                                              Passive immunization of mice with this MAb resulted in r
92                                              Passive immunization of murine models of Alzheimer disea
93                                              Passive immunization of naive, ablated mice with sera or
94                                      We used passive immunization of neonatal piglets (as a surrogate
95                                 Furthermore, passive immunization of NSCLC tumor-bearing mice with ne
96 ight be paired with antibiotic treatment for passive immunization of patients suffering from P. aerug
97  different HIV-1 isolates, and used this for passive immunization of pig-tailed macaques.
98                                              Passive immunization of pregnant women with primary HCMV
99                                              Passive immunization of rabbits with M131 administered i
100                                              Passive immunization of susceptible and resistant mouse
101 This report examines the effects of chronic, passive immunization on VAbeta and microhemorrhage in PD
102 l for prophylaxis against HIV-1 infection by passive immunization or gene therapy.
103 ns of ETA, may have therapeutic potential in passive immunization or topical treatment of burn patien
104 from nasopharyngeal infection; however, only passive immunization, or vaccination with inactive SpeA,
105 Abeta monoclonal antibody (mAb) effective in passive immunization paradigm.
106 red to controls (5.64; P = 0.0480), and both passive immunizations (PLY = 31.34% loss of retinal func
107      This compensating effect was blocked by passive immunization pretreatment with the monoclonal Ig
108 ions and to maximize antibody production and passive immunization protocols are being devised.
109 thers have demonstrated that both active and passive immunizations reduce Tau pathology and prevent c
110                We found that both active and passive immunization reduced corneal pathology scores af
111 se combinations might be sought in active or passive immunization regimes.
112  epithelial neutrophil activating protein by passive immunization significantly attenuated neutrophil
113                          Moreover, active or passive immunization significantly reduced S. aureus col
114                              Both active and passive immunization strategies against Staphylococcus a
115 nt, identification of immune correlates, and passive immunization strategies for pertussis.
116                                   Active and passive immunization strategies targeting the CPs protec
117 efore increase the potency and durability of passive immunization strategies to prevent HIV-1 infecti
118 s to date have focused on the development of passive immunization strategies to prevent or treat diss
119 een obtained with both probiotic therapy and passive immunization strategies.
120 timal FcgammaR interactions in the design of passive immunization strategies.
121                                            A passive immunization strategy for treating Ebola virus i
122 e of antibody preparations as a prophylactic passive immunization strategy in large populations.
123 c principles and scientific premises for the passive immunization strategy, including existing and em
124                                              Passive immunization studies are similarly hindered by t
125                                              Passive immunization studies demonstrated that productio
126                              Both active and passive immunization studies have shown that antibodies
127                                     Previous passive immunization studies have suggested that the C-t
128       We addressed this issue in a series of passive immunization studies in Fischer 344 (F344) rats.
129                                 In addition, passive immunization studies showed that specific antibo
130                                     However, passive immunization studies suggested that protection r
131                                              Passive immunization studies, including a recent one by
132                           In both active and passive immunization studies, Osp C (N40) antiserum fail
133 ccine design, our data have implications for passive-immunization studies in countries where clade C
134                               The success of passive immunization suggests that immunoglobulin (Ig)-b
135 psular polysaccharide from A. baumannii as a passive immunization target.
136                                    Active or passive immunizations targeting Abeta are therefore of g
137 clinical studies demonstrate that active and passive immunizations targeting alpha-syn partially amel
138 ct against S. aureus infection of active and passive immunization that targeted 3 proteins involved i
139                                One day after passive immunization, the animals were challenged i.p. w
140  (ARIA) reported in Alzheimer's disease (AD) passive immunization therapies.
141 ely developed is immunotherapy-specifically, passive immunization through administration of exogenous
142                              One approach is passive immunization through the administration of antib
143  and PG16-iMab, are promising candidates for passive immunization to prevent HIV-1 infection.
144 in the presence of maternal immunity or upon passive immunization to rabies virus with the pSG5rab.gp
145                                              Passive immunization using Abeta-specific antibodies has
146 n the absence of an effective HIV-1 vaccine, passive immunization using broadly neutralizing Abs or A
147  of FcRn-transported IgG was demonstrated by passive immunization using herpes simplex virus-2 (HSV-2
148               We have recently reported that passive immunization using monoclonal antibody M131 conv
149                                              Passive immunization using purified IgG from rabbits imm
150 tly, for the first time, we demonstrate that passive immunization using the antibody NT4X is therapeu
151                      In contrast to systemic passive immunization, we observed markedly reduced (>/=8
152 r, virus isolated from 1 mouse 3 weeks after passive immunization with 13.2 mg/kg antibody proved res
153                                              Passive immunization with 2B11 increased neutrophil infi
154 e protected against lethality by intravenous passive immunization with a CPB antibody prior to intrag
155                                              Passive immunization with a rabbit antiserum against dLO
156 als, no safety concerns were identified with passive immunization with a single bNAb (VRC01).
157                                              Passive immunization with Ab doses resulting in serum Ig
158                                              Passive immunization with Abs against whole C. parvum or
159                                    Active or passive immunization with alpha-toxin toxoid could prote
160 vent or treat AD, we compared the effects of passive immunization with an anti-Abeta42 mAb, an anti-A
161  laboratory has previously demonstrated that passive immunization with an anti-tau antibody, HJ8.5, d
162                                              Passive immunization with an antibody directed against t
163                                              Passive immunization with an antibody directed to an epi
164 e protected against lethality by intravenous passive immunization with an epsilon toxin antibody prio
165 ion with the amyloid beta (Abeta) protein or passive immunization with anti-Abeta antibodies has bene
166  protein transgenic mice have suggested that passive immunization with anti-Abeta antibodies may clea
167                     Finally, the efficacy of passive immunization with anti-Abeta antibodies on the c
168                                              Passive immunization with anti-amyloid-beta peptide (Abe
169                                 Importantly, passive immunization with anti-Ftr1p immune sera protect
170                                      Lastly, passive immunization with anti-OmpA MAbs did not confer
171                                              Passive immunization with anti-Sse antiserum also signif
172                                              Passive immunization with anti-tau monoclonal antibodies
173                                              Passive immunization with antibodies against the envelop
174                                    Following passive immunization with antibody, no further adaptive
175                    To evaluate the effect of passive immunization with anticapsular antibodies on nas
176                                              Passive immunization with antisera to these antigens is
177                                              Passive immunization with antiserum to CP5-CRM or CP8-CR
178 he disease are currently available, although passive immunization with C. parvum-specific antibodies
179 ly, studies in these same mice indicate that passive immunization with certain anti-Abeta antibodies
180                                 In primates, passive immunization with combinations containing human
181                                              Passive immunization with each antiserum significantly l
182                                              Passive immunization with either MAb 5C11 or 3E65 partia
183                                              Passive immunization with gammaDPGA mAbs protected >90%
184                                              Passive immunization with Guy's 13 prevents bacterial co
185                                              Passive immunization with hepatitis B surface antibody (
186 on and survival) was completely abrogated by passive immunization with high-titer human anti-MV antib
187                                              Passive immunization with Hla-specific antisera or activ
188                                     Anti-HIV passive immunization with human neutralizing monoclonal
189     We and others have previously shown that passive immunization with human nMAbs protected adult or
190 AIDS, the potential of pre- and postexposure passive immunization with hyperimmune serum to prevent o
191 llenging with the immunizing antigen, and by passive immunization with IgG or IgE anti-2,4,6-trinitro
192                                              Passive immunization with IgG1 and IgG2a mAb protected w
193                                              Passive immunization with immune (convalescent) serum co
194 roups of animals were given one prechallenge passive immunization with immune rabbit serum (IRS), M13
195 uire Ag in sensitized Ig-deficient mice, and passive immunization with immune serum or Ag-specific Ig
196                                              Passive immunization with MAb 3E65 was more effective in
197                                              Passive immunization with MAb 8E7 could significantly en
198                           In wild-type mice, passive immunization with mAb against gp75 or active imm
199                                              Passive immunization with MAb MoPn-40 resulted in a lowe
200        Previously, we have demonstrated that passive immunization with monoclonal antibodies (MAbs) 4
201                                              Passive immunization with monoclonal antibodies (MAbs) s
202                                              Passive immunization with monoclonal antibodies (MAbs) t
203 (FnBPA) and fibronectin-binding protein B or passive immunization with monoclonal antibodies against
204 e to bind to the surface of M. tuberculosis, passive immunization with monoclonal antibodies directed
205                                              Passive immunization with monoclonal antibodies from hum
206                                              Passive immunization with monoclonal antibodies from hum
207 tion with recombinant PR (rPR) molecules and passive immunization with monoclonal antibodies reactive
208 tudies point out some potential drawbacks of passive immunization with monoclonal antibodies.
209                                              Passive immunization with monoclonal antibody TA99 targe
210                  Challenge studies following passive immunization with neutralizing Abs suggest that
211                                              Passive immunization with neutralizing antibodies to IL-
212 pithelial neutrophil activating protein; (2) passive immunization with neutralizing antibodies to TNF
213  immunization with nontoxigenic Hla(H35L) or passive immunization with neutralizing monoclonal antibo
214 udy have implications for the improvement of passive immunization with polyclonal or monoclonal antib
215                                              Passive immunization with pooled sera from recombinant A
216 al challenge with P. yoelii sporozoites than passive immunization with purified IgG from rabbits immu
217                                              Passive immunization with rabbit antibodies against E. f
218 Active immunization with recombinant SasX or passive immunization with rabbit polyclonal anti-SasX Ig
219 ne mice challenged by transplantation and by passive immunization with sera from mice infected with e
220 amyloid peptide (Alphabeta) with vaccines or passive immunization with systemic monoclonal anti-Abeta
221 he aim of this study is to determine whether passive immunization with the 23-valent pneumococcal pol
222                          Here we report that passive immunization with the broadly neutralizing antib
223   This study reports the effect of active or passive immunization with the conjugates or their antise
224                                              Passive immunization with the rabbit antisera resulted i
225                                 Importantly, passive immunization with the recombinant HBc-E2 particl
226                       Our data indicate that passive immunization with this anti-Abeta monoclonal ant
227                                              Passive immunization with this antibody resulted in prot
228                                              Passive immunizations with antisera targeting outer memb

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top